Aethlon Medical Inc Market Cap ($1.11 Million)
Market Cap & Net Worth: Aethlon Medical Inc (AEMD)
Aethlon Medical Inc market cap. Aethlon Medical Inc (NASDAQ:AEMD) has a market capitalization of $1.11 Million ($1.11 Million) as of November 4, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #30605 globally and #6230 in its home market, demonstrating a 4.75% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Aethlon Medical Inc's stock price $5.29 by its total outstanding shares 711136 (711.14K). Also see AEMD operating cash flow for how efficiently the company converts equity into cash flow.
Aethlon Medical Inc Market Cap History (2015–2026)
Aethlon Medical Inc market cap history from 2015 to 2026. Data shows change from $724.29 Million to $3.76 Million (-37.99% CAGR). Check Aethlon Medical Inc stock price for real-time trading data and today's change.
Index Memberships
Aethlon Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #895 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2837 of 3165 |
Weight: Aethlon Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Aethlon Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Aethlon Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Aethlon Medical Inc (AEMD) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
2.71x
Aethlon Medical Inc's market cap is 2.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $120.54 Million | $392.07K | -$7.28 Million | 307.44x | N/A |
| 2018 | $177.07 Million | $149.62K | -$5.68 Million | 1183.44x | N/A |
| 2019 | $6.85 Million | $229.62K | -$6.20 Million | 29.82x | N/A |
| 2020 | $17.57 Million | $650.19K | -$6.37 Million | 27.02x | N/A |
| 2021 | $13.23 Million | $659.10K | -$7.85 Million | 20.07x | N/A |
| 2022 | $1.96 Million | $294.17K | -$10.42 Million | 6.66x | N/A |
| 2023 | $1.56 Million | $574.25K | -$12.03 Million | 2.71x | N/A |
Competitor Companies of AEMD by Market Capitalization
Companies near Aethlon Medical Inc in the global market cap rankings as of November 4, 2026. Also see AEMD total asset value for a full breakdown of the balance sheet.
Key companies related to Aethlon Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Aethlon Medical Inc (2015–2026)
Market capitalization of Aethlon Medical Inc from 2015 to today. Between 2015 and today, Aethlon Medical Inc's market cap moved from $724.29 Million to $ 3.76 Million, with a yearly change of -37.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.76 Million | +90.97% |
| 2025 | $1.97 Million | +222.09% |
| 2024 | $611.58K | -60.73% |
| 2023 | $1.56 Million | -20.48% |
| 2022 | $1.96 Million | -85.19% |
| 2021 | $13.23 Million | -24.70% |
| 2020 | $17.57 Million | +156.49% |
| 2019 | $6.85 Million | -96.13% |
| 2018 | $177.07 Million | +46.90% |
| 2017 | $120.54 Million | -73.10% |
| 2016 | $448.02 Million | -38.14% |
| 2015 | $724.29 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Aethlon Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.11 Million USD |
| MoneyControl | $1.11 Million USD |
| MarketWatch | $1.11 Million USD |
| marketcap.company | $1.11 Million USD |
| Reuters | $1.11 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.